Skip to main content
. 2017 May 22;8(37):61264–61281. doi: 10.18632/oncotarget.18057

Figure 4. The abnormal metabolic pathways involved in pancreatic ductal adenocarcinoma based on characteristic metabolites in serum metabonomes.

Figure 4

(A), Panc-1 cell induced subcutaneous xenograft model; (B), Panc-1 cell induced orthotopic xenograft model; (C), BxPC-3 cell induced subcutaneous xenograft model; (D), BxPC-3 cell induced orthotopic xenograft model. Abbreviations for the metabolites are listed in Table 1.